nodes	percent_of_prediction	percent_of_DWPC	metapath
Metformin—Azotaemia—Carmustine—malignant glioma	0.00387	0.041	CcSEcCtD
Metformin—Rigors—Temozolomide—malignant glioma	0.00244	0.0259	CcSEcCtD
Metformin—Accidental injury—Carmustine—malignant glioma	0.00233	0.0247	CcSEcCtD
Metformin—Neuropathy—Carmustine—malignant glioma	0.00194	0.0205	CcSEcCtD
Metformin—Neuropathy—Temozolomide—malignant glioma	0.00187	0.0198	CcSEcCtD
Metformin—Ear pain—Temozolomide—malignant glioma	0.00169	0.018	CcSEcCtD
Metformin—Injury—Carmustine—malignant glioma	0.00163	0.0173	CcSEcCtD
Metformin—Nasal congestion—Temozolomide—malignant glioma	0.00159	0.0168	CcSEcCtD
Metformin—Liver function test abnormal—Carmustine—malignant glioma	0.00138	0.0146	CcSEcCtD
Metformin—Dehydration—Temozolomide—malignant glioma	0.00134	0.0143	CcSEcCtD
Metformin—NDUFC1—medulla oblongata—malignant glioma	0.00132	0.00323	CbGeAlD
Metformin—Breast disorder—Temozolomide—malignant glioma	0.00131	0.0139	CcSEcCtD
Metformin—NDUFAF1—medulla oblongata—malignant glioma	0.00129	0.00318	CbGeAlD
Metformin—ND6—medulla oblongata—malignant glioma	0.00128	0.00315	CbGeAlD
Metformin—NDUFAF2—medulla oblongata—malignant glioma	0.00127	0.00312	CbGeAlD
Metformin—NDUFB3—medulla oblongata—malignant glioma	0.00127	0.00312	CbGeAlD
Metformin—NDUFA2—midbrain—malignant glioma	0.00127	0.00312	CbGeAlD
Metformin—NDUFC2—retina—malignant glioma	0.00126	0.00309	CbGeAlD
Metformin—Abdominal distension—Temozolomide—malignant glioma	0.00126	0.0133	CcSEcCtD
Metformin—NDUFA11—medulla oblongata—malignant glioma	0.00124	0.00305	CbGeAlD
Metformin—NDUFA5—medulla oblongata—malignant glioma	0.00124	0.00305	CbGeAlD
Metformin—NDUFA2—spinal cord—malignant glioma	0.00124	0.00305	CbGeAlD
Metformin—NDUFS3—brainstem—malignant glioma	0.00124	0.00304	CbGeAlD
Metformin—NDUFB6—medulla oblongata—malignant glioma	0.00123	0.00303	CbGeAlD
Metformin—NDUFAF4—medulla oblongata—malignant glioma	0.00123	0.00303	CbGeAlD
Metformin—PRKAB1—telencephalon—malignant glioma	0.00123	0.00301	CbGeAlD
Metformin—NDUFS1—medulla oblongata—malignant glioma	0.00123	0.00301	CbGeAlD
Metformin—Sweating increased—Temozolomide—malignant glioma	0.00122	0.0129	CcSEcCtD
Metformin—NDUFB10—medulla oblongata—malignant glioma	0.00122	0.00299	CbGeAlD
Metformin—NDUFV3—brain—malignant glioma	0.00122	0.00299	CbGeAlD
Metformin—NDUFA9—central nervous system—malignant glioma	0.00122	0.00298	CbGeAlD
Metformin—NDUFA13—central nervous system—malignant glioma	0.00122	0.00298	CbGeAlD
Metformin—NDUFA10—midbrain—malignant glioma	0.00121	0.00298	CbGeAlD
Metformin—NDUFS2—retina—malignant glioma	0.00121	0.00297	CbGeAlD
Metformin—Neutropenia—Carmustine—malignant glioma	0.00121	0.0128	CcSEcCtD
Metformin—NDUFA12—medulla oblongata—malignant glioma	0.00121	0.00296	CbGeAlD
Metformin—NDUFB7—medulla oblongata—malignant glioma	0.00121	0.00296	CbGeAlD
Metformin—NDUFC1—midbrain—malignant glioma	0.0012	0.00295	CbGeAlD
Metformin—NDUFB1—medulla oblongata—malignant glioma	0.0012	0.00294	CbGeAlD
Metformin—NDUFS8—medulla oblongata—malignant glioma	0.0012	0.00294	CbGeAlD
Metformin—NDUFA1—central nervous system—malignant glioma	0.0012	0.00294	CbGeAlD
Metformin—NDUFB2—midbrain—malignant glioma	0.00119	0.00293	CbGeAlD
Metformin—NDUFA13—cerebellum—malignant glioma	0.00119	0.00292	CbGeAlD
Metformin—NDUFA10—spinal cord—malignant glioma	0.00118	0.00291	CbGeAlD
Metformin—NDUFB5—medulla oblongata—malignant glioma	0.00118	0.0029	CbGeAlD
Metformin—NDUFA6—medulla oblongata—malignant glioma	0.00118	0.0029	CbGeAlD
Metformin—NDUFS6—brain—malignant glioma	0.00118	0.0029	CbGeAlD
Metformin—NDUFAF1—midbrain—malignant glioma	0.00118	0.0029	CbGeAlD
Metformin—NDUFS4—medulla oblongata—malignant glioma	0.00118	0.00289	CbGeAlD
Metformin—NDUFC1—spinal cord—malignant glioma	0.00117	0.00288	CbGeAlD
Metformin—ND6—midbrain—malignant glioma	0.00117	0.00288	CbGeAlD
Metformin—Neutropenia—Temozolomide—malignant glioma	0.00117	0.0124	CcSEcCtD
Metformin—NDUFB2—spinal cord—malignant glioma	0.00116	0.00286	CbGeAlD
Metformin—NDUFAF2—midbrain—malignant glioma	0.00116	0.00286	CbGeAlD
Metformin—NDUFB3—midbrain—malignant glioma	0.00116	0.00286	CbGeAlD
Metformin—NDUFV2—central nervous system—malignant glioma	0.00116	0.00285	CbGeAlD
Metformin—Upper respiratory tract infection—Temozolomide—malignant glioma	0.00116	0.0123	CcSEcCtD
Metformin—NDUFB4—medulla oblongata—malignant glioma	0.00116	0.00285	CbGeAlD
Metformin—NDUFC2—telencephalon—malignant glioma	0.00116	0.00284	CbGeAlD
Metformin—NDUFAF1—spinal cord—malignant glioma	0.00115	0.00283	CbGeAlD
Metformin—NDUFAB1—medulla oblongata—malignant glioma	0.00115	0.00283	CbGeAlD
Metformin—NDUFA7—brain—malignant glioma	0.00115	0.00283	CbGeAlD
Metformin—NDUFA8—medulla oblongata—malignant glioma	0.00115	0.00281	CbGeAlD
Metformin—NDUFB9—medulla oblongata—malignant glioma	0.00115	0.00281	CbGeAlD
Metformin—NDUFA4—medulla oblongata—malignant glioma	0.00114	0.0028	CbGeAlD
Metformin—NDUFA5—midbrain—malignant glioma	0.00114	0.00279	CbGeAlD
Metformin—NDUFA11—midbrain—malignant glioma	0.00114	0.00279	CbGeAlD
Metformin—NDUFB3—spinal cord—malignant glioma	0.00114	0.00279	CbGeAlD
Metformin—NDUFAF2—spinal cord—malignant glioma	0.00114	0.00279	CbGeAlD
Metformin—NDUFV2—cerebellum—malignant glioma	0.00114	0.00279	CbGeAlD
Metformin—NDUFV1—medulla oblongata—malignant glioma	0.00113	0.00278	CbGeAlD
Metformin—NDUFB11—medulla oblongata—malignant glioma	0.00113	0.00278	CbGeAlD
Metformin—Neuropathy peripheral—Carmustine—malignant glioma	0.00113	0.012	CcSEcCtD
Metformin—NDUFB6—midbrain—malignant glioma	0.00113	0.00277	CbGeAlD
Metformin—NDUFAF4—midbrain—malignant glioma	0.00113	0.00277	CbGeAlD
Metformin—NDUFB8—medulla oblongata—malignant glioma	0.00113	0.00276	CbGeAlD
Metformin—NDUFS5—medulla oblongata—malignant glioma	0.00113	0.00276	CbGeAlD
Metformin—NDUFS1—midbrain—malignant glioma	0.00112	0.00275	CbGeAlD
Metformin—Infestation—Temozolomide—malignant glioma	0.00111	0.0118	CcSEcCtD
Metformin—Infestation NOS—Temozolomide—malignant glioma	0.00111	0.0118	CcSEcCtD
Metformin—NDUFS2—telencephalon—malignant glioma	0.00111	0.00273	CbGeAlD
Metformin—NDUFB10—midbrain—malignant glioma	0.00111	0.00273	CbGeAlD
Metformin—NDUFA11—spinal cord—malignant glioma	0.00111	0.00272	CbGeAlD
Metformin—NDUFA4L2—cerebellum—malignant glioma	0.0011	0.00271	CbGeAlD
Metformin—NDUFA12—midbrain—malignant glioma	0.0011	0.00271	CbGeAlD
Metformin—NDUFB7—midbrain—malignant glioma	0.0011	0.00271	CbGeAlD
Metformin—NDUFAF4—spinal cord—malignant glioma	0.0011	0.0027	CbGeAlD
Metformin—NDUFB6—spinal cord—malignant glioma	0.0011	0.0027	CbGeAlD
Metformin—SLC29A4—brain—malignant glioma	0.0011	0.0027	CbGeAlD
Metformin—NDUFS3—telencephalon—malignant glioma	0.0011	0.0027	CbGeAlD
Metformin—NDUFB1—midbrain—malignant glioma	0.0011	0.00269	CbGeAlD
Metformin—NDUFS8—midbrain—malignant glioma	0.0011	0.00269	CbGeAlD
Metformin—NDUFS1—spinal cord—malignant glioma	0.00109	0.00268	CbGeAlD
Metformin—Neuropathy peripheral—Temozolomide—malignant glioma	0.00109	0.0116	CcSEcCtD
Metformin—NDUFB10—spinal cord—malignant glioma	0.00109	0.00266	CbGeAlD
Metformin—NDUFB5—midbrain—malignant glioma	0.00108	0.00265	CbGeAlD
Metformin—NDUFA6—midbrain—malignant glioma	0.00108	0.00265	CbGeAlD
Metformin—NDUFB7—spinal cord—malignant glioma	0.00108	0.00264	CbGeAlD
Metformin—NDUFA12—spinal cord—malignant glioma	0.00108	0.00264	CbGeAlD
Metformin—NDUFAF3—brain—malignant glioma	0.00108	0.00264	CbGeAlD
Metformin—NDUFS4—midbrain—malignant glioma	0.00107	0.00264	CbGeAlD
Metformin—NDUFB1—spinal cord—malignant glioma	0.00107	0.00263	CbGeAlD
Metformin—NDUFS8—spinal cord—malignant glioma	0.00107	0.00263	CbGeAlD
Metformin—ND4L—central nervous system—malignant glioma	0.00106	0.00261	CbGeAlD
Metformin—ND2—central nervous system—malignant glioma	0.00106	0.00261	CbGeAlD
Metformin—ND3—central nervous system—malignant glioma	0.00106	0.00261	CbGeAlD
Metformin—ND5—central nervous system—malignant glioma	0.00106	0.00261	CbGeAlD
Metformin—NDUFB4—midbrain—malignant glioma	0.00106	0.0026	CbGeAlD
Metformin—NDUFB5—spinal cord—malignant glioma	0.00106	0.00259	CbGeAlD
Metformin—NDUFA6—spinal cord—malignant glioma	0.00106	0.00259	CbGeAlD
Metformin—NDUFAB1—midbrain—malignant glioma	0.00105	0.00259	CbGeAlD
Metformin—Hepatobiliary disease—Temozolomide—malignant glioma	0.00105	0.0112	CcSEcCtD
Metformin—NDUFS4—spinal cord—malignant glioma	0.00105	0.00257	CbGeAlD
Metformin—NDUFB9—midbrain—malignant glioma	0.00105	0.00257	CbGeAlD
Metformin—NDUFA8—midbrain—malignant glioma	0.00105	0.00257	CbGeAlD
Metformin—NDUFA4—midbrain—malignant glioma	0.00104	0.00256	CbGeAlD
Metformin—NDUFB11—midbrain—malignant glioma	0.00104	0.00254	CbGeAlD
Metformin—NDUFV1—midbrain—malignant glioma	0.00104	0.00254	CbGeAlD
Metformin—NDUFB4—spinal cord—malignant glioma	0.00104	0.00254	CbGeAlD
Metformin—Hypoaesthesia—Carmustine—malignant glioma	0.00103	0.0109	CcSEcCtD
Metformin—NDUFS5—midbrain—malignant glioma	0.00103	0.00253	CbGeAlD
Metformin—NDUFB8—midbrain—malignant glioma	0.00103	0.00253	CbGeAlD
Metformin—NDUFAB1—spinal cord—malignant glioma	0.00103	0.00252	CbGeAlD
Metformin—ND4—central nervous system—malignant glioma	0.00103	0.00252	CbGeAlD
Metformin—NDUFB9—spinal cord—malignant glioma	0.00102	0.00251	CbGeAlD
Metformin—NDUFA8—spinal cord—malignant glioma	0.00102	0.00251	CbGeAlD
Metformin—Oedema peripheral—Carmustine—malignant glioma	0.00102	0.0108	CcSEcCtD
Metformin—Connective tissue disorder—Carmustine—malignant glioma	0.00102	0.0108	CcSEcCtD
Metformin—NDUFA4—spinal cord—malignant glioma	0.00102	0.00249	CbGeAlD
Metformin—NDUFV1—spinal cord—malignant glioma	0.00101	0.00248	CbGeAlD
Metformin—NDUFB11—spinal cord—malignant glioma	0.00101	0.00248	CbGeAlD
Metformin—NDUFS5—spinal cord—malignant glioma	0.001	0.00246	CbGeAlD
Metformin—NDUFB8—spinal cord—malignant glioma	0.001	0.00246	CbGeAlD
Metformin—Hepatitis—Temozolomide—malignant glioma	0.001	0.0106	CcSEcCtD
Metformin—Hypoaesthesia—Temozolomide—malignant glioma	0.000995	0.0106	CcSEcCtD
Metformin—Oedema peripheral—Temozolomide—malignant glioma	0.000985	0.0104	CcSEcCtD
Metformin—NDUFA2—cerebellum—malignant glioma	0.000984	0.00242	CbGeAlD
Metformin—Connective tissue disorder—Temozolomide—malignant glioma	0.000983	0.0104	CcSEcCtD
Metformin—Eye disorder—Carmustine—malignant glioma	0.000967	0.0103	CcSEcCtD
Metformin—PRKAB1—medulla oblongata—malignant glioma	0.000965	0.00237	CbGeAlD
Metformin—NDUFA13—brain—malignant glioma	0.000965	0.00237	CbGeAlD
Metformin—NDUFA9—brain—malignant glioma	0.000965	0.00237	CbGeAlD
Metformin—NDUFS7—midbrain—malignant glioma	0.000964	0.00237	CbGeAlD
Metformin—NDUFA10—central nervous system—malignant glioma	0.000961	0.00236	CbGeAlD
Metformin—Flushing—Carmustine—malignant glioma	0.000961	0.0102	CcSEcCtD
Metformin—NDUFC1—central nervous system—malignant glioma	0.000952	0.00234	CbGeAlD
Metformin—NDUFA1—brain—malignant glioma	0.00095	0.00233	CbGeAlD
Metformin—NDUFB2—central nervous system—malignant glioma	0.000944	0.00232	CbGeAlD
Metformin—NDUFS7—spinal cord—malignant glioma	0.000941	0.00231	CbGeAlD
Metformin—NDUFA10—cerebellum—malignant glioma	0.000939	0.0023	CbGeAlD
Metformin—NDUFAF1—central nervous system—malignant glioma	0.000936	0.0023	CbGeAlD
Metformin—Eye disorder—Temozolomide—malignant glioma	0.000935	0.00991	CcSEcCtD
Metformin—NDUFC1—cerebellum—malignant glioma	0.000931	0.00228	CbGeAlD
Metformin—ND6—central nervous system—malignant glioma	0.000929	0.00228	CbGeAlD
Metformin—Cardiac disorder—Temozolomide—malignant glioma	0.000928	0.00984	CcSEcCtD
Metformin—Flushing—Temozolomide—malignant glioma	0.000928	0.00984	CcSEcCtD
Metformin—NDUFB2—cerebellum—malignant glioma	0.000923	0.00226	CbGeAlD
Metformin—NDUFV2—brain—malignant glioma	0.000922	0.00226	CbGeAlD
Metformin—NDUFAF2—central nervous system—malignant glioma	0.000921	0.00226	CbGeAlD
Metformin—NDUFAF1—cerebellum—malignant glioma	0.000915	0.00225	CbGeAlD
Metformin—ND1—telencephalon—malignant glioma	0.000913	0.00224	CbGeAlD
Metformin—NDUFC2—medulla oblongata—malignant glioma	0.000909	0.00223	CbGeAlD
Metformin—ND6—cerebellum—malignant glioma	0.000908	0.00223	CbGeAlD
Metformin—Angiopathy—Temozolomide—malignant glioma	0.000907	0.00962	CcSEcCtD
Metformin—Immune system disorder—Temozolomide—malignant glioma	0.000903	0.00958	CcSEcCtD
Metformin—Mediastinal disorder—Temozolomide—malignant glioma	0.000901	0.00956	CcSEcCtD
Metformin—Erythema—Carmustine—malignant glioma	0.000901	0.00955	CcSEcCtD
Metformin—Malnutrition—Carmustine—malignant glioma	0.000901	0.00955	CcSEcCtD
Metformin—NDUFB3—cerebellum—malignant glioma	0.0009	0.00221	CbGeAlD
Metformin—NDUFAF2—cerebellum—malignant glioma	0.0009	0.00221	CbGeAlD
Metformin—NDUFA5—central nervous system—malignant glioma	0.0009	0.00221	CbGeAlD
Metformin—NDUFA11—central nervous system—malignant glioma	0.0009	0.00221	CbGeAlD
Metformin—Chills—Temozolomide—malignant glioma	0.000897	0.00952	CcSEcCtD
Metformin—NDUFA4L2—brain—malignant glioma	0.000897	0.0022	CbGeAlD
Metformin—NDUFB6—central nervous system—malignant glioma	0.000893	0.00219	CbGeAlD
Metformin—NDUFAF4—central nervous system—malignant glioma	0.000893	0.00219	CbGeAlD
Metformin—NDUFS1—central nervous system—malignant glioma	0.000887	0.00218	CbGeAlD
Metformin—NDUFB10—central nervous system—malignant glioma	0.00088	0.00216	CbGeAlD
Metformin—NDUFA11—cerebellum—malignant glioma	0.00088	0.00216	CbGeAlD
Metformin—NDUFA5—cerebellum—malignant glioma	0.00088	0.00216	CbGeAlD
Metformin—NDUFS2—medulla oblongata—malignant glioma	0.000874	0.00215	CbGeAlD
Metformin—NDUFA12—central nervous system—malignant glioma	0.000874	0.00214	CbGeAlD
Metformin—NDUFB7—central nervous system—malignant glioma	0.000874	0.00214	CbGeAlD
Metformin—NDUFB6—cerebellum—malignant glioma	0.000873	0.00214	CbGeAlD
Metformin—NDUFAF4—cerebellum—malignant glioma	0.000873	0.00214	CbGeAlD
Metformin—Erythema—Temozolomide—malignant glioma	0.000871	0.00923	CcSEcCtD
Metformin—Malnutrition—Temozolomide—malignant glioma	0.000871	0.00923	CcSEcCtD
Metformin—NDUFB1—central nervous system—malignant glioma	0.000868	0.00213	CbGeAlD
Metformin—NDUFS8—central nervous system—malignant glioma	0.000868	0.00213	CbGeAlD
Metformin—NDUFS1—cerebellum—malignant glioma	0.000867	0.00213	CbGeAlD
Metformin—NDUFS3—medulla oblongata—malignant glioma	0.000864	0.00212	CbGeAlD
Metformin—PRKAB1—spinal cord—malignant glioma	0.000861	0.00211	CbGeAlD
Metformin—NDUFB10—cerebellum—malignant glioma	0.00086	0.00211	CbGeAlD
Metformin—NDUFA6—central nervous system—malignant glioma	0.000856	0.0021	CbGeAlD
Metformin—NDUFB5—central nervous system—malignant glioma	0.000856	0.0021	CbGeAlD
Metformin—NDUFB7—cerebellum—malignant glioma	0.000854	0.0021	CbGeAlD
Metformin—NDUFA12—cerebellum—malignant glioma	0.000854	0.0021	CbGeAlD
Metformin—Dysgeusia—Temozolomide—malignant glioma	0.000853	0.00904	CcSEcCtD
Metformin—NDUFS4—central nervous system—malignant glioma	0.000851	0.00209	CbGeAlD
Metformin—Vision blurred—Carmustine—malignant glioma	0.000849	0.009	CcSEcCtD
Metformin—NDUFS8—cerebellum—malignant glioma	0.000848	0.00208	CbGeAlD
Metformin—NDUFB1—cerebellum—malignant glioma	0.000848	0.00208	CbGeAlD
Metformin—Tremor—Carmustine—malignant glioma	0.000844	0.00895	CcSEcCtD
Metformin—ND3—brain—malignant glioma	0.000843	0.00207	CbGeAlD
Metformin—ND2—brain—malignant glioma	0.000843	0.00207	CbGeAlD
Metformin—ND5—brain—malignant glioma	0.000843	0.00207	CbGeAlD
Metformin—ND4L—brain—malignant glioma	0.000843	0.00207	CbGeAlD
Metformin—NDUFB4—central nervous system—malignant glioma	0.00084	0.00206	CbGeAlD
Metformin—NDUFA6—cerebellum—malignant glioma	0.000837	0.00205	CbGeAlD
Metformin—NDUFB5—cerebellum—malignant glioma	0.000837	0.00205	CbGeAlD
Metformin—NDUFAB1—central nervous system—malignant glioma	0.000835	0.00205	CbGeAlD
Metformin—NDUFS4—cerebellum—malignant glioma	0.000832	0.00204	CbGeAlD
Metformin—NDUFC2—midbrain—malignant glioma	0.000831	0.00204	CbGeAlD
Metformin—NDUFB9—central nervous system—malignant glioma	0.000829	0.00204	CbGeAlD
Metformin—NDUFA8—central nervous system—malignant glioma	0.000829	0.00204	CbGeAlD
Metformin—NDUFA4—central nervous system—malignant glioma	0.000824	0.00202	CbGeAlD
Metformin—NDUFB4—cerebellum—malignant glioma	0.000821	0.00201	CbGeAlD
Metformin—Vision blurred—Temozolomide—malignant glioma	0.000821	0.0087	CcSEcCtD
Metformin—NDUFV1—central nervous system—malignant glioma	0.000819	0.00201	CbGeAlD
Metformin—NDUFB11—central nervous system—malignant glioma	0.000819	0.00201	CbGeAlD
Metformin—ND4—brain—malignant glioma	0.000816	0.002	CbGeAlD
Metformin—Tremor—Temozolomide—malignant glioma	0.000816	0.00865	CcSEcCtD
Metformin—NDUFAB1—cerebellum—malignant glioma	0.000816	0.002	CbGeAlD
Metformin—NDUFS5—central nervous system—malignant glioma	0.000815	0.002	CbGeAlD
Metformin—NDUFB8—central nervous system—malignant glioma	0.000815	0.002	CbGeAlD
Metformin—NDUFC2—spinal cord—malignant glioma	0.000811	0.00199	CbGeAlD
Metformin—NDUFA8—cerebellum—malignant glioma	0.000811	0.00199	CbGeAlD
Metformin—NDUFB9—cerebellum—malignant glioma	0.000811	0.00199	CbGeAlD
Metformin—Ill-defined disorder—Temozolomide—malignant glioma	0.000808	0.00857	CcSEcCtD
Metformin—NDUFA4—cerebellum—malignant glioma	0.000806	0.00198	CbGeAlD
Metformin—NDUFB11—cerebellum—malignant glioma	0.000801	0.00197	CbGeAlD
Metformin—NDUFV1—cerebellum—malignant glioma	0.000801	0.00197	CbGeAlD
Metformin—NDUFA2—brain—malignant glioma	0.0008	0.00196	CbGeAlD
Metformin—NDUFS2—midbrain—malignant glioma	0.000799	0.00196	CbGeAlD
Metformin—NDUFS5—cerebellum—malignant glioma	0.000796	0.00195	CbGeAlD
Metformin—NDUFB8—cerebellum—malignant glioma	0.000796	0.00195	CbGeAlD
Metformin—NDUFS3—midbrain—malignant glioma	0.000789	0.00194	CbGeAlD
Metformin—Malaise—Temozolomide—malignant glioma	0.000785	0.00833	CcSEcCtD
Metformin—NDUFS2—spinal cord—malignant glioma	0.00078	0.00191	CbGeAlD
Metformin—Hypertension—Carmustine—malignant glioma	0.000778	0.00825	CcSEcCtD
Metformin—NDUFS3—spinal cord—malignant glioma	0.00077	0.00189	CbGeAlD
Metformin—Palpitations—Temozolomide—malignant glioma	0.000769	0.00816	CcSEcCtD
Metformin—Chest pain—Carmustine—malignant glioma	0.000767	0.00813	CcSEcCtD
Metformin—Myalgia—Carmustine—malignant glioma	0.000767	0.00813	CcSEcCtD
Metformin—NDUFS7—central nervous system—malignant glioma	0.000763	0.00187	CbGeAlD
Metformin—NDUFA10—brain—malignant glioma	0.000763	0.00187	CbGeAlD
Metformin—NDUFC1—brain—malignant glioma	0.000756	0.00186	CbGeAlD
Metformin—Hypertension—Temozolomide—malignant glioma	0.000752	0.00797	CcSEcCtD
Metformin—NDUFB2—brain—malignant glioma	0.00075	0.00184	CbGeAlD
Metformin—NDUFS7—cerebellum—malignant glioma	0.000746	0.00183	CbGeAlD
Metformin—NDUFAF1—brain—malignant glioma	0.000743	0.00182	CbGeAlD
Metformin—Myalgia—Temozolomide—malignant glioma	0.000741	0.00786	CcSEcCtD
Metformin—ND6—brain—malignant glioma	0.000737	0.00181	CbGeAlD
Metformin—Unspecified disorder of skin and subcutaneous tissue—Temozolomide—malignant glioma	0.000736	0.00781	CcSEcCtD
Metformin—Oedema—Carmustine—malignant glioma	0.000735	0.0078	CcSEcCtD
Metformin—Discomfort—Temozolomide—malignant glioma	0.000732	0.00777	CcSEcCtD
Metformin—NDUFAF2—brain—malignant glioma	0.000731	0.00179	CbGeAlD
Metformin—NDUFB3—brain—malignant glioma	0.000731	0.00179	CbGeAlD
Metformin—Infection—Carmustine—malignant glioma	0.000731	0.00775	CcSEcCtD
Metformin—Thrombocytopenia—Carmustine—malignant glioma	0.00072	0.00763	CcSEcCtD
Metformin—NDUFA5—brain—malignant glioma	0.000714	0.00175	CbGeAlD
Metformin—NDUFA11—brain—malignant glioma	0.000714	0.00175	CbGeAlD
Metformin—Oedema—Temozolomide—malignant glioma	0.000711	0.00753	CcSEcCtD
Metformin—NDUFB6—brain—malignant glioma	0.000709	0.00174	CbGeAlD
Metformin—NDUFAF4—brain—malignant glioma	0.000709	0.00174	CbGeAlD
Metformin—Infection—Temozolomide—malignant glioma	0.000706	0.00749	CcSEcCtD
Metformin—NDUFS1—brain—malignant glioma	0.000704	0.00173	CbGeAlD
Metformin—Anorexia—Carmustine—malignant glioma	0.000701	0.00743	CcSEcCtD
Metformin—NDUFB10—brain—malignant glioma	0.000699	0.00171	CbGeAlD
Metformin—SLC47A1—brainstem—malignant glioma	0.000699	0.00171	CbGeAlD
Metformin—PRKAB1—central nervous system—malignant glioma	0.000698	0.00171	CbGeAlD
Metformin—Nervous system disorder—Temozolomide—malignant glioma	0.000697	0.00739	CcSEcCtD
Metformin—Thrombocytopenia—Temozolomide—malignant glioma	0.000696	0.00738	CcSEcCtD
Metformin—NDUFA12—brain—malignant glioma	0.000694	0.0017	CbGeAlD
Metformin—NDUFB7—brain—malignant glioma	0.000694	0.0017	CbGeAlD
Metformin—Skin disorder—Temozolomide—malignant glioma	0.00069	0.00732	CcSEcCtD
Metformin—NDUFB1—brain—malignant glioma	0.000689	0.00169	CbGeAlD
Metformin—NDUFS8—brain—malignant glioma	0.000689	0.00169	CbGeAlD
Metformin—Hypotension—Carmustine—malignant glioma	0.000687	0.00729	CcSEcCtD
Metformin—Hyperhidrosis—Temozolomide—malignant glioma	0.000687	0.00728	CcSEcCtD
Metformin—PRKAB1—cerebellum—malignant glioma	0.000682	0.00167	CbGeAlD
Metformin—NDUFA6—brain—malignant glioma	0.00068	0.00167	CbGeAlD
Metformin—NDUFB5—brain—malignant glioma	0.00068	0.00167	CbGeAlD
Metformin—Anorexia—Temozolomide—malignant glioma	0.000677	0.00718	CcSEcCtD
Metformin—NDUFS4—brain—malignant glioma	0.000675	0.00166	CbGeAlD
Metformin—Musculoskeletal discomfort—Carmustine—malignant glioma	0.00067	0.0071	CcSEcCtD
Metformin—NDUFB4—brain—malignant glioma	0.000667	0.00164	CbGeAlD
Metformin—NDUFAB1—brain—malignant glioma	0.000663	0.00163	CbGeAlD
Metformin—Paraesthesia—Carmustine—malignant glioma	0.00066	0.007	CcSEcCtD
Metformin—NDUFA8—brain—malignant glioma	0.000658	0.00162	CbGeAlD
Metformin—NDUFB9—brain—malignant glioma	0.000658	0.00162	CbGeAlD
Metformin—NDUFC2—central nervous system—malignant glioma	0.000658	0.00161	CbGeAlD
Metformin—Dyspnoea—Carmustine—malignant glioma	0.000656	0.00695	CcSEcCtD
Metformin—NDUFA4—brain—malignant glioma	0.000654	0.00161	CbGeAlD
Metformin—Somnolence—Carmustine—malignant glioma	0.000654	0.00693	CcSEcCtD
Metformin—NDUFB11—brain—malignant glioma	0.000651	0.0016	CbGeAlD
Metformin—NDUFV1—brain—malignant glioma	0.000651	0.0016	CbGeAlD
Metformin—Musculoskeletal discomfort—Temozolomide—malignant glioma	0.000647	0.00686	CcSEcCtD
Metformin—NDUFB8—brain—malignant glioma	0.000647	0.00159	CbGeAlD
Metformin—NDUFS5—brain—malignant glioma	0.000647	0.00159	CbGeAlD
Metformin—NDUFC2—cerebellum—malignant glioma	0.000643	0.00158	CbGeAlD
Metformin—Decreased appetite—Carmustine—malignant glioma	0.000639	0.00678	CcSEcCtD
Metformin—Paraesthesia—Temozolomide—malignant glioma	0.000638	0.00677	CcSEcCtD
Metformin—Gastrointestinal disorder—Carmustine—malignant glioma	0.000635	0.00673	CcSEcCtD
Metformin—Dyspnoea—Temozolomide—malignant glioma	0.000634	0.00672	CcSEcCtD
Metformin—NDUFS2—central nervous system—malignant glioma	0.000632	0.00155	CbGeAlD
Metformin—Somnolence—Temozolomide—malignant glioma	0.000632	0.0067	CcSEcCtD
Metformin—Constipation—Carmustine—malignant glioma	0.000629	0.00667	CcSEcCtD
Metformin—Dyspepsia—Temozolomide—malignant glioma	0.000626	0.00663	CcSEcCtD
Metformin—NDUFS3—central nervous system—malignant glioma	0.000625	0.00153	CbGeAlD
Metformin—NDUFS2—cerebellum—malignant glioma	0.000618	0.00152	CbGeAlD
Metformin—Decreased appetite—Temozolomide—malignant glioma	0.000618	0.00655	CcSEcCtD
Metformin—Gastrointestinal disorder—Temozolomide—malignant glioma	0.000613	0.00651	CcSEcCtD
Metformin—Fatigue—Temozolomide—malignant glioma	0.000613	0.0065	CcSEcCtD
Metformin—NDUFS3—cerebellum—malignant glioma	0.000611	0.0015	CbGeAlD
Metformin—SLC22A3—embryo—malignant glioma	0.000608	0.00149	CbGeAlD
Metformin—Constipation—Temozolomide—malignant glioma	0.000608	0.00644	CcSEcCtD
Metformin—NDUFS7—brain—malignant glioma	0.000606	0.00149	CbGeAlD
Metformin—Feeling abnormal—Carmustine—malignant glioma	0.000606	0.00643	CcSEcCtD
Metformin—Gastrointestinal pain—Carmustine—malignant glioma	0.000601	0.00638	CcSEcCtD
Metformin—Feeling abnormal—Temozolomide—malignant glioma	0.000586	0.00621	CcSEcCtD
Metformin—Abdominal pain—Carmustine—malignant glioma	0.000581	0.00616	CcSEcCtD
Metformin—Gastrointestinal pain—Temozolomide—malignant glioma	0.000581	0.00616	CcSEcCtD
Metformin—Urticaria—Temozolomide—malignant glioma	0.000565	0.00599	CcSEcCtD
Metformin—Abdominal pain—Temozolomide—malignant glioma	0.000562	0.00596	CcSEcCtD
Metformin—PRKAB1—brain—malignant glioma	0.000554	0.00136	CbGeAlD
Metformin—Asthenia—Carmustine—malignant glioma	0.000528	0.00559	CcSEcCtD
Metformin—NDUFC2—brain—malignant glioma	0.000522	0.00128	CbGeAlD
Metformin—ND1—central nervous system—malignant glioma	0.000519	0.00127	CbGeAlD
Metformin—SLC22A1—telencephalon—malignant glioma	0.000517	0.00127	CbGeAlD
Metformin—Asthenia—Temozolomide—malignant glioma	0.00051	0.00541	CcSEcCtD
Metformin—Diarrhoea—Carmustine—malignant glioma	0.000503	0.00533	CcSEcCtD
Metformin—Pruritus—Temozolomide—malignant glioma	0.000503	0.00533	CcSEcCtD
Metformin—NDUFS2—brain—malignant glioma	0.000502	0.00123	CbGeAlD
Metformin—NDUFS3—brain—malignant glioma	0.000496	0.00122	CbGeAlD
Metformin—SLC47A1—medulla oblongata—malignant glioma	0.000487	0.0012	CbGeAlD
Metformin—Dizziness—Carmustine—malignant glioma	0.000486	0.00516	CcSEcCtD
Metformin—Diarrhoea—Temozolomide—malignant glioma	0.000486	0.00516	CcSEcCtD
Metformin—Dizziness—Temozolomide—malignant glioma	0.00047	0.00498	CcSEcCtD
Metformin—Vomiting—Carmustine—malignant glioma	0.000468	0.00496	CcSEcCtD
Metformin—Rash—Carmustine—malignant glioma	0.000464	0.00492	CcSEcCtD
Metformin—Dermatitis—Carmustine—malignant glioma	0.000463	0.00491	CcSEcCtD
Metformin—Headache—Carmustine—malignant glioma	0.000461	0.00488	CcSEcCtD
Metformin—Vomiting—Temozolomide—malignant glioma	0.000452	0.00479	CcSEcCtD
Metformin—Rash—Temozolomide—malignant glioma	0.000448	0.00475	CcSEcCtD
Metformin—Dermatitis—Temozolomide—malignant glioma	0.000448	0.00475	CcSEcCtD
Metformin—Headache—Temozolomide—malignant glioma	0.000445	0.00472	CcSEcCtD
Metformin—Nausea—Carmustine—malignant glioma	0.000437	0.00463	CcSEcCtD
Metformin—SLC47A1—spinal cord—malignant glioma	0.000435	0.00107	CbGeAlD
Metformin—Nausea—Temozolomide—malignant glioma	0.000422	0.00448	CcSEcCtD
Metformin—ND1—brain—malignant glioma	0.000412	0.00101	CbGeAlD
Metformin—SLC47A1—central nervous system—malignant glioma	0.000352	0.000865	CbGeAlD
Metformin—SLC47A1—cerebellum—malignant glioma	0.000345	0.000845	CbGeAlD
Metformin—SLC22A1—central nervous system—malignant glioma	0.000294	0.000722	CbGeAlD
Metformin—SLC22A3—central nervous system—malignant glioma	0.000281	0.00069	CbGeAlD
Metformin—SLC47A1—brain—malignant glioma	0.00028	0.000687	CbGeAlD
Metformin—SLC22A1—brain—malignant glioma	0.000234	0.000573	CbGeAlD
Metformin—SLC22A3—brain—malignant glioma	0.000223	0.000548	CbGeAlD
Metformin—NDUFV1—Metabolism—PTEN—malignant glioma	2.69e-05	5.39e-05	CbGpPWpGaD
Metformin—NDUFA8—Metabolism—PTEN—malignant glioma	2.69e-05	5.39e-05	CbGpPWpGaD
Metformin—NDUFB9—Metabolism—PTEN—malignant glioma	2.69e-05	5.39e-05	CbGpPWpGaD
Metformin—NDUFA3—Metabolism—PTEN—malignant glioma	2.69e-05	5.39e-05	CbGpPWpGaD
Metformin—NDUFA9—Metabolism—PTEN—malignant glioma	2.69e-05	5.39e-05	CbGpPWpGaD
Metformin—NDUFB7—Metabolism—PTEN—malignant glioma	2.69e-05	5.39e-05	CbGpPWpGaD
Metformin—SLC22A1—Metabolism—COX8A—malignant glioma	2.68e-05	5.39e-05	CbGpPWpGaD
Metformin—ND1—Metabolism—NCOR1—malignant glioma	2.67e-05	5.36e-05	CbGpPWpGaD
Metformin—SLC22A1—Transmission across Chemical Synapses—BRAF—malignant glioma	2.63e-05	5.28e-05	CbGpPWpGaD
Metformin—SLC22A3—Metabolism—IDH1—malignant glioma	2.55e-05	5.11e-05	CbGpPWpGaD
Metformin—NDUFS2—Metabolism—PIK3CD—malignant glioma	2.54e-05	5.1e-05	CbGpPWpGaD
Metformin—PRKAB1—Signaling Pathways—NOTCH2—malignant glioma	2.53e-05	5.07e-05	CbGpPWpGaD
Metformin—PRKAB1—Signaling Pathways—KNG1—malignant glioma	2.47e-05	4.96e-05	CbGpPWpGaD
Metformin—SLC22A3—Metabolism—SPHK1—malignant glioma	2.46e-05	4.94e-05	CbGpPWpGaD
Metformin—SLC22A2—Metabolism—ASMT—malignant glioma	2.45e-05	4.92e-05	CbGpPWpGaD
Metformin—SLC22A2—Transmembrane transport of small molecules—TFRC—malignant glioma	2.45e-05	4.92e-05	CbGpPWpGaD
Metformin—SLC22A3—Metabolism—CYP2C18—malignant glioma	2.41e-05	4.84e-05	CbGpPWpGaD
Metformin—NDUFV3—Metabolism—PTEN—malignant glioma	2.39e-05	4.81e-05	CbGpPWpGaD
Metformin—SLC22A2—Transmission across Chemical Synapses—MDM2—malignant glioma	2.36e-05	4.74e-05	CbGpPWpGaD
Metformin—NDUFS3—Metabolism—PIK3CB—malignant glioma	2.36e-05	4.73e-05	CbGpPWpGaD
Metformin—NDUFS7—Metabolism—PIK3CB—malignant glioma	2.36e-05	4.73e-05	CbGpPWpGaD
Metformin—NDUFC2—Metabolism—PIK3CB—malignant glioma	2.36e-05	4.73e-05	CbGpPWpGaD
Metformin—PRKAB1—Signaling Pathways—NTRK1—malignant glioma	2.36e-05	4.73e-05	CbGpPWpGaD
Metformin—SLC22A2—Transmission across Chemical Synapses—RAF1—malignant glioma	2.35e-05	4.73e-05	CbGpPWpGaD
Metformin—NDUFS7—Metabolism—PTGS2—malignant glioma	2.33e-05	4.69e-05	CbGpPWpGaD
Metformin—NDUFC2—Metabolism—PTGS2—malignant glioma	2.33e-05	4.69e-05	CbGpPWpGaD
Metformin—NDUFS3—Metabolism—PTGS2—malignant glioma	2.33e-05	4.69e-05	CbGpPWpGaD
Metformin—SLC22A2—Metabolism—BCAN—malignant glioma	2.3e-05	4.62e-05	CbGpPWpGaD
Metformin—SLC22A1—Metabolism—ASMT—malignant glioma	2.28e-05	4.58e-05	CbGpPWpGaD
Metformin—SLC22A1—Transmembrane transport of small molecules—TFRC—malignant glioma	2.28e-05	4.58e-05	CbGpPWpGaD
Metformin—SLC22A2—Transmembrane transport of small molecules—SLC5A5—malignant glioma	2.25e-05	4.51e-05	CbGpPWpGaD
Metformin—NDUFB11—Metabolism—PIK3CA—malignant glioma	2.23e-05	4.47e-05	CbGpPWpGaD
Metformin—NDUFS2—Metabolism—PIK3CB—malignant glioma	2.21e-05	4.45e-05	CbGpPWpGaD
Metformin—SLC22A1—Transmission across Chemical Synapses—MDM2—malignant glioma	2.2e-05	4.42e-05	CbGpPWpGaD
Metformin—SLC22A1—Transmission across Chemical Synapses—RAF1—malignant glioma	2.19e-05	4.41e-05	CbGpPWpGaD
Metformin—NDUFS2—Metabolism—PTGS2—malignant glioma	2.19e-05	4.41e-05	CbGpPWpGaD
Metformin—PRKAB1—Signaling Pathways—MMP3—malignant glioma	2.19e-05	4.4e-05	CbGpPWpGaD
Metformin—ND1—Metabolism—CAV1—malignant glioma	2.17e-05	4.37e-05	CbGpPWpGaD
Metformin—PRKAB1—Signaling Pathways—CDKN2B—malignant glioma	2.17e-05	4.36e-05	CbGpPWpGaD
Metformin—SLC22A2—Neuronal System—BRAF—malignant glioma	2.16e-05	4.34e-05	CbGpPWpGaD
Metformin—SLC22A1—Metabolism—BCAN—malignant glioma	2.15e-05	4.31e-05	CbGpPWpGaD
Metformin—SLC22A2—Transmembrane transport of small molecules—SLC6A3—malignant glioma	2.14e-05	4.3e-05	CbGpPWpGaD
Metformin—PRKAB1—Signaling Pathways—PTK2—malignant glioma	2.11e-05	4.23e-05	CbGpPWpGaD
Metformin—SLC22A1—Transmembrane transport of small molecules—SLC5A5—malignant glioma	2.1e-05	4.21e-05	CbGpPWpGaD
Metformin—PRKAB1—Signaling Pathways—HES1—malignant glioma	2.07e-05	4.16e-05	CbGpPWpGaD
Metformin—PRKAB1—Signaling Pathways—NCOR1—malignant glioma	2.06e-05	4.13e-05	CbGpPWpGaD
Metformin—NDUFA12—Metabolism—PIK3CA—malignant glioma	2.04e-05	4.09e-05	CbGpPWpGaD
Metformin—NDUFA11—Metabolism—PIK3CA—malignant glioma	2.04e-05	4.09e-05	CbGpPWpGaD
Metformin—NDUFB3—Metabolism—PIK3CA—malignant glioma	2.04e-05	4.09e-05	CbGpPWpGaD
Metformin—NDUFA1—Metabolism—PIK3CA—malignant glioma	2.04e-05	4.09e-05	CbGpPWpGaD
Metformin—NDUFC2—Metabolism—PTEN—malignant glioma	2.04e-05	4.09e-05	CbGpPWpGaD
Metformin—NDUFS3—Metabolism—PTEN—malignant glioma	2.04e-05	4.09e-05	CbGpPWpGaD
Metformin—NDUFS7—Metabolism—PTEN—malignant glioma	2.04e-05	4.09e-05	CbGpPWpGaD
Metformin—SLC22A1—Neuronal System—BRAF—malignant glioma	2.01e-05	4.04e-05	CbGpPWpGaD
Metformin—SLC22A1—Transmembrane transport of small molecules—SLC6A3—malignant glioma	1.99e-05	4e-05	CbGpPWpGaD
Metformin—ND1—Metabolism—PIK3CG—malignant glioma	1.98e-05	3.98e-05	CbGpPWpGaD
Metformin—PRKAB1—Signaling Pathways—PDGFRA—malignant glioma	1.97e-05	3.96e-05	CbGpPWpGaD
Metformin—SLC22A3—Metabolism—GSTT1—malignant glioma	1.95e-05	3.92e-05	CbGpPWpGaD
Metformin—PRKAB1—Signaling Pathways—SPP1—malignant glioma	1.91e-05	3.84e-05	CbGpPWpGaD
Metformin—NDUFS2—Metabolism—PTEN—malignant glioma	1.91e-05	3.84e-05	CbGpPWpGaD
Metformin—ND1—Metabolism—PPARG—malignant glioma	1.91e-05	3.84e-05	CbGpPWpGaD
Metformin—ND2—Metabolism—PIK3CA—malignant glioma	1.89e-05	3.8e-05	CbGpPWpGaD
Metformin—NDUFS6—Metabolism—PIK3CA—malignant glioma	1.89e-05	3.8e-05	CbGpPWpGaD
Metformin—NDUFB9—Metabolism—PIK3CA—malignant glioma	1.89e-05	3.8e-05	CbGpPWpGaD
Metformin—NDUFA9—Metabolism—PIK3CA—malignant glioma	1.89e-05	3.8e-05	CbGpPWpGaD
Metformin—NDUFB6—Metabolism—PIK3CA—malignant glioma	1.89e-05	3.8e-05	CbGpPWpGaD
Metformin—NDUFA6—Metabolism—PIK3CA—malignant glioma	1.89e-05	3.8e-05	CbGpPWpGaD
Metformin—ND4L—Metabolism—PIK3CA—malignant glioma	1.89e-05	3.8e-05	CbGpPWpGaD
Metformin—NDUFB5—Metabolism—PIK3CA—malignant glioma	1.89e-05	3.8e-05	CbGpPWpGaD
Metformin—ND4—Metabolism—PIK3CA—malignant glioma	1.89e-05	3.8e-05	CbGpPWpGaD
Metformin—NDUFB4—Metabolism—PIK3CA—malignant glioma	1.89e-05	3.8e-05	CbGpPWpGaD
Metformin—NDUFA2—Metabolism—PIK3CA—malignant glioma	1.89e-05	3.8e-05	CbGpPWpGaD
Metformin—NDUFB10—Metabolism—PIK3CA—malignant glioma	1.89e-05	3.8e-05	CbGpPWpGaD
Metformin—NDUFB7—Metabolism—PIK3CA—malignant glioma	1.89e-05	3.8e-05	CbGpPWpGaD
Metformin—NDUFS5—Metabolism—PIK3CA—malignant glioma	1.89e-05	3.8e-05	CbGpPWpGaD
Metformin—NDUFV2—Metabolism—PIK3CA—malignant glioma	1.89e-05	3.8e-05	CbGpPWpGaD
Metformin—NDUFC1—Metabolism—PIK3CA—malignant glioma	1.89e-05	3.8e-05	CbGpPWpGaD
Metformin—NDUFAB1—Metabolism—PIK3CA—malignant glioma	1.89e-05	3.8e-05	CbGpPWpGaD
Metformin—NDUFA10—Metabolism—PIK3CA—malignant glioma	1.89e-05	3.8e-05	CbGpPWpGaD
Metformin—NDUFB1—Metabolism—PIK3CA—malignant glioma	1.89e-05	3.8e-05	CbGpPWpGaD
Metformin—NDUFB8—Metabolism—PIK3CA—malignant glioma	1.89e-05	3.8e-05	CbGpPWpGaD
Metformin—NDUFA5—Metabolism—PIK3CA—malignant glioma	1.89e-05	3.8e-05	CbGpPWpGaD
Metformin—ND6—Metabolism—PIK3CA—malignant glioma	1.89e-05	3.8e-05	CbGpPWpGaD
Metformin—NDUFS1—Metabolism—PIK3CA—malignant glioma	1.89e-05	3.8e-05	CbGpPWpGaD
Metformin—NDUFA7—Metabolism—PIK3CA—malignant glioma	1.89e-05	3.8e-05	CbGpPWpGaD
Metformin—NDUFB2—Metabolism—PIK3CA—malignant glioma	1.89e-05	3.8e-05	CbGpPWpGaD
Metformin—NDUFA4—Metabolism—PIK3CA—malignant glioma	1.89e-05	3.8e-05	CbGpPWpGaD
Metformin—NDUFS8—Metabolism—PIK3CA—malignant glioma	1.89e-05	3.8e-05	CbGpPWpGaD
Metformin—NDUFA8—Metabolism—PIK3CA—malignant glioma	1.89e-05	3.8e-05	CbGpPWpGaD
Metformin—ND5—Metabolism—PIK3CA—malignant glioma	1.89e-05	3.8e-05	CbGpPWpGaD
Metformin—NDUFS4—Metabolism—PIK3CA—malignant glioma	1.89e-05	3.8e-05	CbGpPWpGaD
Metformin—NDUFV1—Metabolism—PIK3CA—malignant glioma	1.89e-05	3.8e-05	CbGpPWpGaD
Metformin—ND3—Metabolism—PIK3CA—malignant glioma	1.89e-05	3.8e-05	CbGpPWpGaD
Metformin—NDUFA13—Metabolism—PIK3CA—malignant glioma	1.89e-05	3.8e-05	CbGpPWpGaD
Metformin—NDUFA3—Metabolism—PIK3CA—malignant glioma	1.89e-05	3.8e-05	CbGpPWpGaD
Metformin—SLC22A2—Metabolism—IDH2—malignant glioma	1.86e-05	3.73e-05	CbGpPWpGaD
Metformin—SLC22A3—Metabolism—PTGS1—malignant glioma	1.83e-05	3.67e-05	CbGpPWpGaD
Metformin—NDUFB11—Metabolism—AKT1—malignant glioma	1.82e-05	3.65e-05	CbGpPWpGaD
Metformin—PRKAB1—Signaling Pathways—TERT—malignant glioma	1.81e-05	3.64e-05	CbGpPWpGaD
Metformin—SLC22A2—Neuronal System—MDM2—malignant glioma	1.81e-05	3.63e-05	CbGpPWpGaD
Metformin—SLC22A2—Neuronal System—RAF1—malignant glioma	1.8e-05	3.62e-05	CbGpPWpGaD
Metformin—PRKAB1—Signaling Pathways—PDGFB—malignant glioma	1.77e-05	3.55e-05	CbGpPWpGaD
Metformin—PRKAB1—Signaling Pathways—FGFR1—malignant glioma	1.76e-05	3.54e-05	CbGpPWpGaD
Metformin—SLC22A2—Metabolism—CYP2B6—malignant glioma	1.75e-05	3.5e-05	CbGpPWpGaD
Metformin—ND1—Metabolism—PIK3CD—malignant glioma	1.74e-05	3.5e-05	CbGpPWpGaD
Metformin—PRKAB1—Signaling Pathways—HIF1A—malignant glioma	1.74e-05	3.48e-05	CbGpPWpGaD
Metformin—SLC22A1—Metabolism—IDH2—malignant glioma	1.73e-05	3.47e-05	CbGpPWpGaD
Metformin—SLC22A3—Metabolism—BCHE—malignant glioma	1.7e-05	3.41e-05	CbGpPWpGaD
Metformin—NDUFV3—Metabolism—PIK3CA—malignant glioma	1.69e-05	3.39e-05	CbGpPWpGaD
Metformin—SLC22A1—Neuronal System—MDM2—malignant glioma	1.69e-05	3.39e-05	CbGpPWpGaD
Metformin—SLC22A1—Neuronal System—RAF1—malignant glioma	1.68e-05	3.38e-05	CbGpPWpGaD
Metformin—SLC22A3—Metabolism—SLC5A5—malignant glioma	1.68e-05	3.37e-05	CbGpPWpGaD
Metformin—PRKAB1—Signaling Pathways—CAV1—malignant glioma	1.68e-05	3.37e-05	CbGpPWpGaD
Metformin—NDUFA11—Metabolism—AKT1—malignant glioma	1.66e-05	3.34e-05	CbGpPWpGaD
Metformin—NDUFA1—Metabolism—AKT1—malignant glioma	1.66e-05	3.34e-05	CbGpPWpGaD
Metformin—NDUFB3—Metabolism—AKT1—malignant glioma	1.66e-05	3.34e-05	CbGpPWpGaD
Metformin—NDUFA12—Metabolism—AKT1—malignant glioma	1.66e-05	3.34e-05	CbGpPWpGaD
Metformin—PRKAB1—Signaling Pathways—KDR—malignant glioma	1.66e-05	3.33e-05	CbGpPWpGaD
Metformin—SLC22A1—Metabolism—CYP2B6—malignant glioma	1.63e-05	3.27e-05	CbGpPWpGaD
Metformin—PRKAB1—Signaling Pathways—F2—malignant glioma	1.6e-05	3.21e-05	CbGpPWpGaD
Metformin—PRKAB1—Signaling Pathways—FN1—malignant glioma	1.6e-05	3.21e-05	CbGpPWpGaD
Metformin—SLC22A2—Metabolism—IDH1—malignant glioma	1.6e-05	3.2e-05	CbGpPWpGaD
Metformin—PRKAB1—Signaling Pathways—BAD—malignant glioma	1.58e-05	3.17e-05	CbGpPWpGaD
Metformin—PRKAB1—Signaling Pathways—NOTCH1—malignant glioma	1.56e-05	3.14e-05	CbGpPWpGaD
Metformin—ND2—Metabolism—AKT1—malignant glioma	1.55e-05	3.11e-05	CbGpPWpGaD
Metformin—NDUFB9—Metabolism—AKT1—malignant glioma	1.55e-05	3.11e-05	CbGpPWpGaD
Metformin—NDUFB6—Metabolism—AKT1—malignant glioma	1.55e-05	3.11e-05	CbGpPWpGaD
Metformin—ND3—Metabolism—AKT1—malignant glioma	1.55e-05	3.11e-05	CbGpPWpGaD
Metformin—NDUFS6—Metabolism—AKT1—malignant glioma	1.55e-05	3.11e-05	CbGpPWpGaD
Metformin—NDUFA3—Metabolism—AKT1—malignant glioma	1.55e-05	3.11e-05	CbGpPWpGaD
Metformin—NDUFV1—Metabolism—AKT1—malignant glioma	1.55e-05	3.11e-05	CbGpPWpGaD
Metformin—NDUFA7—Metabolism—AKT1—malignant glioma	1.55e-05	3.11e-05	CbGpPWpGaD
Metformin—NDUFB2—Metabolism—AKT1—malignant glioma	1.55e-05	3.11e-05	CbGpPWpGaD
Metformin—NDUFB1—Metabolism—AKT1—malignant glioma	1.55e-05	3.11e-05	CbGpPWpGaD
Metformin—NDUFA5—Metabolism—AKT1—malignant glioma	1.55e-05	3.11e-05	CbGpPWpGaD
Metformin—NDUFA10—Metabolism—AKT1—malignant glioma	1.55e-05	3.11e-05	CbGpPWpGaD
Metformin—NDUFA13—Metabolism—AKT1—malignant glioma	1.55e-05	3.11e-05	CbGpPWpGaD
Metformin—NDUFAB1—Metabolism—AKT1—malignant glioma	1.55e-05	3.11e-05	CbGpPWpGaD
Metformin—ND6—Metabolism—AKT1—malignant glioma	1.55e-05	3.11e-05	CbGpPWpGaD
Metformin—NDUFA2—Metabolism—AKT1—malignant glioma	1.55e-05	3.11e-05	CbGpPWpGaD
Metformin—NDUFS8—Metabolism—AKT1—malignant glioma	1.55e-05	3.11e-05	CbGpPWpGaD
Metformin—NDUFA4—Metabolism—AKT1—malignant glioma	1.55e-05	3.11e-05	CbGpPWpGaD
Metformin—ND4L—Metabolism—AKT1—malignant glioma	1.55e-05	3.11e-05	CbGpPWpGaD
Metformin—NDUFA8—Metabolism—AKT1—malignant glioma	1.55e-05	3.11e-05	CbGpPWpGaD
Metformin—NDUFB4—Metabolism—AKT1—malignant glioma	1.55e-05	3.11e-05	CbGpPWpGaD
Metformin—NDUFB8—Metabolism—AKT1—malignant glioma	1.55e-05	3.11e-05	CbGpPWpGaD
Metformin—NDUFV2—Metabolism—AKT1—malignant glioma	1.55e-05	3.11e-05	CbGpPWpGaD
Metformin—ND5—Metabolism—AKT1—malignant glioma	1.55e-05	3.11e-05	CbGpPWpGaD
Metformin—NDUFB7—Metabolism—AKT1—malignant glioma	1.55e-05	3.11e-05	CbGpPWpGaD
Metformin—NDUFA6—Metabolism—AKT1—malignant glioma	1.55e-05	3.11e-05	CbGpPWpGaD
Metformin—NDUFS4—Metabolism—AKT1—malignant glioma	1.55e-05	3.11e-05	CbGpPWpGaD
Metformin—NDUFS1—Metabolism—AKT1—malignant glioma	1.55e-05	3.11e-05	CbGpPWpGaD
Metformin—NDUFC1—Metabolism—AKT1—malignant glioma	1.55e-05	3.11e-05	CbGpPWpGaD
Metformin—NDUFA9—Metabolism—AKT1—malignant glioma	1.55e-05	3.11e-05	CbGpPWpGaD
Metformin—ND4—Metabolism—AKT1—malignant glioma	1.55e-05	3.11e-05	CbGpPWpGaD
Metformin—NDUFB5—Metabolism—AKT1—malignant glioma	1.55e-05	3.11e-05	CbGpPWpGaD
Metformin—NDUFS5—Metabolism—AKT1—malignant glioma	1.55e-05	3.11e-05	CbGpPWpGaD
Metformin—NDUFB10—Metabolism—AKT1—malignant glioma	1.55e-05	3.11e-05	CbGpPWpGaD
Metformin—SLC22A3—Transmembrane transport of small molecules—RAF1—malignant glioma	1.55e-05	3.1e-05	CbGpPWpGaD
Metformin—SLC22A2—Metabolism—SPHK1—malignant glioma	1.54e-05	3.1e-05	CbGpPWpGaD
Metformin—PRKAB1—Signaling Pathways—CD80—malignant glioma	1.53e-05	3.07e-05	CbGpPWpGaD
Metformin—PRKAB1—Signaling Pathways—PIK3CG—malignant glioma	1.53e-05	3.07e-05	CbGpPWpGaD
Metformin—PRKAB1—Signaling Pathways—APC—malignant glioma	1.53e-05	3.07e-05	CbGpPWpGaD
Metformin—ND1—Metabolism—PIK3CB—malignant glioma	1.52e-05	3.05e-05	CbGpPWpGaD
Metformin—SLC22A2—Metabolism—CYP2C18—malignant glioma	1.51e-05	3.04e-05	CbGpPWpGaD
Metformin—PRKAB1—Signaling Pathways—EGF—malignant glioma	1.51e-05	3.03e-05	CbGpPWpGaD
Metformin—ND1—Metabolism—PTGS2—malignant glioma	1.5e-05	3.02e-05	CbGpPWpGaD
Metformin—PRKAB1—Signaling Pathways—PTPN11—malignant glioma	1.5e-05	3.01e-05	CbGpPWpGaD
Metformin—SLC22A1—Metabolism—IDH1—malignant glioma	1.49e-05	2.99e-05	CbGpPWpGaD
Metformin—SLC22A1—Metabolism—SPHK1—malignant glioma	1.44e-05	2.89e-05	CbGpPWpGaD
Metformin—PRKAB1—Signaling Pathways—BRAF—malignant glioma	1.44e-05	2.88e-05	CbGpPWpGaD
Metformin—NDUFS3—Metabolism—PIK3CA—malignant glioma	1.44e-05	2.88e-05	CbGpPWpGaD
Metformin—NDUFC2—Metabolism—PIK3CA—malignant glioma	1.44e-05	2.88e-05	CbGpPWpGaD
Metformin—NDUFS7—Metabolism—PIK3CA—malignant glioma	1.44e-05	2.88e-05	CbGpPWpGaD
Metformin—SLC22A1—Metabolism—CYP2C18—malignant glioma	1.41e-05	2.83e-05	CbGpPWpGaD
Metformin—PRKAB1—Signaling Pathways—AKT2—malignant glioma	1.4e-05	2.81e-05	CbGpPWpGaD
Metformin—NDUFV3—Metabolism—AKT1—malignant glioma	1.38e-05	2.77e-05	CbGpPWpGaD
Metformin—SLC22A3—Metabolism—GSTP1—malignant glioma	1.35e-05	2.72e-05	CbGpPWpGaD
Metformin—NDUFS2—Metabolism—PIK3CA—malignant glioma	1.35e-05	2.71e-05	CbGpPWpGaD
Metformin—PRKAB1—Signaling Pathways—PIK3CD—malignant glioma	1.34e-05	2.7e-05	CbGpPWpGaD
Metformin—SLC22A3—Metabolism—CAT—malignant glioma	1.32e-05	2.64e-05	CbGpPWpGaD
Metformin—ND1—Metabolism—PTEN—malignant glioma	1.31e-05	2.63e-05	CbGpPWpGaD
Metformin—PRKAB1—Signaling Pathways—FGF2—malignant glioma	1.29e-05	2.58e-05	CbGpPWpGaD
Metformin—SLC22A3—Metabolism—NCOR1—malignant glioma	1.24e-05	2.5e-05	CbGpPWpGaD
Metformin—SLC22A2—Metabolism—GSTT1—malignant glioma	1.22e-05	2.46e-05	CbGpPWpGaD
Metformin—PRKAB1—Signaling Pathways—MDM2—malignant glioma	1.2e-05	2.42e-05	CbGpPWpGaD
Metformin—PRKAB1—Signaling Pathways—RAF1—malignant glioma	1.2e-05	2.41e-05	CbGpPWpGaD
Metformin—PRKAB1—Signaling Pathways—ERBB2—malignant glioma	1.19e-05	2.38e-05	CbGpPWpGaD
Metformin—NDUFS7—Metabolism—AKT1—malignant glioma	1.17e-05	2.35e-05	CbGpPWpGaD
Metformin—NDUFS3—Metabolism—AKT1—malignant glioma	1.17e-05	2.35e-05	CbGpPWpGaD
Metformin—NDUFC2—Metabolism—AKT1—malignant glioma	1.17e-05	2.35e-05	CbGpPWpGaD
Metformin—PRKAB1—Signaling Pathways—PIK3CB—malignant glioma	1.17e-05	2.35e-05	CbGpPWpGaD
Metformin—SLC22A2—Metabolism—PTGS1—malignant glioma	1.15e-05	2.3e-05	CbGpPWpGaD
Metformin—SLC22A1—Metabolism—GSTT1—malignant glioma	1.14e-05	2.29e-05	CbGpPWpGaD
Metformin—PRKAB1—Signaling Pathways—CXCL8—malignant glioma	1.13e-05	2.26e-05	CbGpPWpGaD
Metformin—NDUFS2—Metabolism—AKT1—malignant glioma	1.1e-05	2.21e-05	CbGpPWpGaD
Metformin—PRKAB1—Signaling Pathways—CASP3—malignant glioma	1.08e-05	2.16e-05	CbGpPWpGaD
Metformin—PRKAB1—Signaling Pathways—IL2—malignant glioma	1.08e-05	2.16e-05	CbGpPWpGaD
Metformin—SLC22A1—Metabolism—PTGS1—malignant glioma	1.07e-05	2.15e-05	CbGpPWpGaD
Metformin—SLC22A2—Metabolism—BCHE—malignant glioma	1.07e-05	2.14e-05	CbGpPWpGaD
Metformin—SLC22A2—Metabolism—SLC5A5—malignant glioma	1.05e-05	2.11e-05	CbGpPWpGaD
Metformin—PRKAB1—Signaling Pathways—MMP9—malignant glioma	1.02e-05	2.04e-05	CbGpPWpGaD
Metformin—SLC22A3—Metabolism—CAV1—malignant glioma	1.01e-05	2.03e-05	CbGpPWpGaD
Metformin—PRKAB1—Signaling Pathways—PTEN—malignant glioma	1.01e-05	2.03e-05	CbGpPWpGaD
Metformin—SLC22A1—Metabolism—BCHE—malignant glioma	9.94e-06	1.99e-05	CbGpPWpGaD
Metformin—SLC22A1—Metabolism—SLC5A5—malignant glioma	9.82e-06	1.97e-05	CbGpPWpGaD
Metformin—SLC22A2—Transmembrane transport of small molecules—RAF1—malignant glioma	9.7e-06	1.95e-05	CbGpPWpGaD
Metformin—ND1—Metabolism—PIK3CA—malignant glioma	9.25e-06	1.86e-05	CbGpPWpGaD
Metformin—SLC22A3—Metabolism—PIK3CG—malignant glioma	9.23e-06	1.85e-05	CbGpPWpGaD
Metformin—PRKAB1—Signaling Pathways—VEGFA—malignant glioma	9.14e-06	1.84e-05	CbGpPWpGaD
Metformin—PRKAB1—Signaling Pathways—STAT3—malignant glioma	9.05e-06	1.82e-05	CbGpPWpGaD
Metformin—SLC22A1—Transmembrane transport of small molecules—RAF1—malignant glioma	9.04e-06	1.81e-05	CbGpPWpGaD
Metformin—SLC22A3—Metabolism—PPARG—malignant glioma	8.91e-06	1.79e-05	CbGpPWpGaD
Metformin—SLC22A2—Metabolism—GSTP1—malignant glioma	8.48e-06	1.7e-05	CbGpPWpGaD
Metformin—PRKAB1—Signaling Pathways—MYC—malignant glioma	8.41e-06	1.69e-05	CbGpPWpGaD
Metformin—SLC22A2—Metabolism—CAT—malignant glioma	8.25e-06	1.66e-05	CbGpPWpGaD
Metformin—PRKAB1—Signaling Pathways—EGFR—malignant glioma	8.23e-06	1.65e-05	CbGpPWpGaD
Metformin—SLC22A3—Metabolism—PIK3CD—malignant glioma	8.11e-06	1.63e-05	CbGpPWpGaD
Metformin—SLC22A1—Metabolism—GSTP1—malignant glioma	7.91e-06	1.59e-05	CbGpPWpGaD
Metformin—SLC22A2—Metabolism—NCOR1—malignant glioma	7.8e-06	1.56e-05	CbGpPWpGaD
Metformin—PRKAB1—Signaling Pathways—KRAS—malignant glioma	7.77e-06	1.56e-05	CbGpPWpGaD
Metformin—SLC22A1—Metabolism—CAT—malignant glioma	7.69e-06	1.54e-05	CbGpPWpGaD
Metformin—ND1—Metabolism—AKT1—malignant glioma	7.56e-06	1.52e-05	CbGpPWpGaD
Metformin—SLC22A1—Metabolism—NCOR1—malignant glioma	7.27e-06	1.46e-05	CbGpPWpGaD
Metformin—PRKAB1—Signaling Pathways—PIK3CA—malignant glioma	7.14e-06	1.43e-05	CbGpPWpGaD
Metformin—SLC22A3—Metabolism—PIK3CB—malignant glioma	7.07e-06	1.42e-05	CbGpPWpGaD
Metformin—SLC22A3—Metabolism—PTGS2—malignant glioma	7.01e-06	1.41e-05	CbGpPWpGaD
Metformin—PRKAB1—Signaling Pathways—TP53—malignant glioma	6.91e-06	1.39e-05	CbGpPWpGaD
Metformin—SLC22A2—Metabolism—CAV1—malignant glioma	6.35e-06	1.28e-05	CbGpPWpGaD
Metformin—SLC22A3—Metabolism—PTEN—malignant glioma	6.11e-06	1.23e-05	CbGpPWpGaD
Metformin—SLC22A1—Metabolism—CAV1—malignant glioma	5.92e-06	1.19e-05	CbGpPWpGaD
Metformin—PRKAB1—Signaling Pathways—AKT1—malignant glioma	5.83e-06	1.17e-05	CbGpPWpGaD
Metformin—SLC22A2—Metabolism—PIK3CG—malignant glioma	5.79e-06	1.16e-05	CbGpPWpGaD
Metformin—SLC22A2—Metabolism—PPARG—malignant glioma	5.59e-06	1.12e-05	CbGpPWpGaD
Metformin—SLC22A1—Metabolism—PIK3CG—malignant glioma	5.4e-06	1.08e-05	CbGpPWpGaD
Metformin—SLC22A1—Metabolism—PPARG—malignant glioma	5.21e-06	1.05e-05	CbGpPWpGaD
Metformin—SLC22A2—Metabolism—PIK3CD—malignant glioma	5.09e-06	1.02e-05	CbGpPWpGaD
Metformin—SLC22A1—Metabolism—PIK3CD—malignant glioma	4.74e-06	9.52e-06	CbGpPWpGaD
Metformin—SLC22A2—Metabolism—PIK3CB—malignant glioma	4.44e-06	8.9e-06	CbGpPWpGaD
Metformin—SLC22A2—Metabolism—PTGS2—malignant glioma	4.39e-06	8.82e-06	CbGpPWpGaD
Metformin—SLC22A3—Metabolism—PIK3CA—malignant glioma	4.31e-06	8.65e-06	CbGpPWpGaD
Metformin—SLC22A1—Metabolism—PIK3CB—malignant glioma	4.13e-06	8.3e-06	CbGpPWpGaD
Metformin—SLC22A1—Metabolism—PTGS2—malignant glioma	4.1e-06	8.22e-06	CbGpPWpGaD
Metformin—SLC22A2—Metabolism—PTEN—malignant glioma	3.83e-06	7.69e-06	CbGpPWpGaD
Metformin—SLC22A1—Metabolism—PTEN—malignant glioma	3.57e-06	7.17e-06	CbGpPWpGaD
Metformin—SLC22A3—Metabolism—AKT1—malignant glioma	3.52e-06	7.07e-06	CbGpPWpGaD
Metformin—SLC22A2—Metabolism—PIK3CA—malignant glioma	2.7e-06	5.43e-06	CbGpPWpGaD
Metformin—SLC22A1—Metabolism—PIK3CA—malignant glioma	2.52e-06	5.06e-06	CbGpPWpGaD
Metformin—SLC22A2—Metabolism—AKT1—malignant glioma	2.21e-06	4.43e-06	CbGpPWpGaD
Metformin—SLC22A1—Metabolism—AKT1—malignant glioma	2.06e-06	4.13e-06	CbGpPWpGaD
